Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunosupressandid - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

argenx - efgartigimod alfa - myasthenia gravis - immunosupressandid - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

gen.orph - miglustaat - gaucheri tõbi - muud alimentary seedetrakti ja ainevahetust tooted, - miglustat gen. orph on näidustatud kerge kuni mõõduka tüüpi 1 imiglütseraas suukaudse ravi. miglustat gen. orph võib kasutada ainult nende patsientide raviks, kellele ensüümi asendamine ravi ei sobi. miglustat gen. orph on näidustatud ravi järk-järgulise neuroloogiliste sümptomite täiskasvanud patsientidel ja lastel patsientidel niemann-pick c-tüüpi haigus.